46 lines
4.5 KiB
Markdown
46 lines
4.5 KiB
Markdown
---
|
|
type: source
|
|
title: "NIH Rescinds DURC/PEPP Implementation Notice; Issues Replacement Mandate Under EO 14292"
|
|
author: "NIH Office of Research"
|
|
url: https://grants.nih.gov/grants/guide/notice-files/NOT-OD-25-112.html
|
|
date: 2025-05-05
|
|
domain: grand-strategy
|
|
secondary_domains: [ai-alignment]
|
|
format: article
|
|
status: unprocessed
|
|
priority: high
|
|
tags: [durc, pepp, biosecurity, ostp, nih, eo-14292, governance-vacuum, replacement-policy, deadline-miss]
|
|
---
|
|
|
|
## Content
|
|
|
|
On May 5, 2025, White House Executive Order 14292 ("Improving the Safety and Security of Biological Research"):
|
|
- Mandated an immediate pause on federally funded "dangerous gain-of-function" (DGOF) research
|
|
- Rescinded the 2024 DURC/PEPP policy (issued May 6, 2024)
|
|
- Charged OSTP with issuing a replacement policy within 120 days (deadline: ~September 2, 2025)
|
|
|
|
NIH responded by rescinding its prior implementation notice NOT-OD-25-061 (which had been preparing researchers for the May 2025 policy implementation). NIH issued NOT-OD-25-112 as the update confirming the EO supersedes the NIH implementation and that a new policy would be issued within 120 days.
|
|
|
|
**Status as of April 23, 2026:** The replacement policy has NOT been issued. This represents a 7.5-month deadline miss (September 2, 2025 deadline missed; no policy as of April 23, 2026).
|
|
|
|
Penn EHRS (University of Pennsylvania Environmental Health & Research Safety) confirmed in their institution update: the original 2024 DURC/PEPP policy was superseded, the EO mandated replacement within 120 days, and no replacement has been issued.
|
|
|
|
GSU URSA (Georgia State University Research Services) confirmed in May 2025 implementation guide update: "A new policy, to be delivered within 120 days, will replace the proposed DURC/PEPP Policy set to take effect May 6, 2025."
|
|
|
|
**Governance gap:** The 2024 DURC/PEPP policy established institutional review committees (IRBs for dual-use research) at universities — the mechanism that determines *which research gets conducted*. The AI Action Plan substitutes (nucleic acid synthesis screening, industry standards) address *how products are screened*, not which research occurs. These are categorically different governance instruments. With the 2024 policy rescinded and no replacement issued after 7.5 months, the institutional review structure for dual-use research is absent.
|
|
|
|
## Agent Notes
|
|
**Why this matters:** The 7.5-month deadline miss on DURC/PEPP (September 2025 deadline → April 2026, still waiting) is structurally parallel to the 11-month absence of a BIS AI Diffusion Framework replacement. Both governance vacuums emerged from the same administration in the same 12-month window. This parallel structure supports the "deliberate reorientation rather than administrative failure" hypothesis (Direction B from 04-22).
|
|
|
|
**What surprised me:** The NIH notice explicitly says "Until the new policy is in place, research meeting the definition of dangerous gain-of-function research is to be paused" — but there is no mechanism to enforce a pause without the institutional review structure that was just rescinded. You cannot pause research you have no mechanism to identify or classify.
|
|
|
|
**What I expected but didn't find:** Any evidence that the September 2025 deadline was met or that a draft replacement was circulating. The absence of any draft or interim guidance after 7.5 months is itself informative — it's not a delay in finalization, it appears to be an absence of drafting.
|
|
|
|
**KB connections:** Directly relates to the DURC/PEPP category substitution claim candidate from 04-22. The 04-22 claim was "the AI Action Plan substitutes screening for institutional oversight" — this source adds the evidence that the institutional oversight structure is now formally rescinded and unreplaced.
|
|
|
|
**Extraction hints:** The NIH rescission of NOT-OD-25-061 is the key document — it formally removes the implementation mechanism. The 7.5-month deadline miss is quantifiable evidence for the governance vacuum claim.
|
|
|
|
## Curator Notes (structured handoff for extractor)
|
|
PRIMARY CONNECTION: DURC/PEPP governance vacuum — the institutional oversight structure is formally absent, not just delayed.
|
|
WHY ARCHIVED: Primary source evidence for the 7.5-month governance deadline miss; parallel to BIS AI Diffusion absence, both support Direction B structural hypothesis.
|
|
EXTRACTION HINT: Extract the parallel with BIS AI Diffusion (both missed by same administration, same window) — this parallelism is the structural argument for deliberate reorientation vs. administrative failure.
|